User profiles for Talía Malagón
 | Talía MalagónAcademic Associate, McGill University Verified email at mcgill.ca Cited by 1370 |
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross-protective …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross-protective …
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model–based analysis
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a nonavalent …
licensed in several countries. Furthermore, clinical trials examining the efficacy of a nonavalent …
Predicted long‐term impact of COVID‐19 pandemic‐related care delays on cancer mortality in Canada
The COVID‐19 pandemic has affected cancer care worldwide. This study aimed to estimate
the long‐term impacts of cancer care disruptions on cancer mortality in Canada using a …
the long‐term impacts of cancer care disruptions on cancer mortality in Canada using a …
Health and economic impact of switching from a 4-valent to a 9-valent HPV vaccination program in the United States
Background: Randomized clinical trials have shown the 9-valent human papillomavirus (HPV)
vaccine to be highly effective against types 31/33/45/52/58 compared with the 4-valent. …
vaccine to be highly effective against types 31/33/45/52/58 compared with the 4-valent. …
[HTML][HTML] Comparing the cost-effectiveness of two-and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study
Background Recent evidence suggests that two doses of HPV vaccines may be as protective
as three doses in the short-term. We estimated the incremental cost-effectiveness of two- …
as three doses in the short-term. We estimated the incremental cost-effectiveness of two- …
Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated women: a modelling study
T Malagón, S Kulasingam, MH Mayrand… - The lancet …, 2018 - thelancet.com
Background There is a paucity of empirical evidence to inform the age at which to stop
cervical cancer screening. The recommended age to stop screening generally varies between …
cervical cancer screening. The recommended age to stop screening generally varies between …
Estimating HPV DNA deposition between sexual partners using HPV concordance, Y chromosome DNA detection, and self-reported sexual behaviors
Background Detection of human papillomavirus (HPV) DNA in genital samples may not
always represent true infections but may be depositions from infected sexual partners. We …
always represent true infections but may be depositions from infected sexual partners. We …
Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study
T Malagón, K Louvanto, M Wissing… - The Lancet Infectious …, 2019 - thelancet.com
Background Hand-to-genital contact is hypothesised to be a transmission mode of human
papillomavirus (HPV) of the Alphapapillomavirus genus. We compared the relative importance …
papillomavirus (HPV) of the Alphapapillomavirus genus. We compared the relative importance …
Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review
Introduction: Vaccine herd effects are the indirect protection that vaccinated persons provide
to those who remain susceptible to infection, due to the reduced transmission of infections. …
to those who remain susceptible to infection, due to the reduced transmission of infections. …
Sex-and type-specific genital human papillomavirus transmission rates between heterosexual partners: a Bayesian reanalysis of the HITCH cohort
Background: It is unclear whether sexual transmission rates of human papillomaviruses (HPV)
differ between sexes and HPV types. We estimate updated transmission rates from the …
differ between sexes and HPV types. We estimate updated transmission rates from the …